These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8024406)

  • 1. Uterine leiomyomas with high content of mast cells.
    Maluf HM; Gersell DJ
    Arch Pathol Lab Med; 1994 Jul; 118(7):712-4. PubMed ID: 8024406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
    Burns B; Curry RH; Bell ME
    Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells.
    Zhu XQ; Lv JQ; Lin Y; Xiang M; Gao BH; Shi YF
    Gynecol Oncol; 2007 Jun; 105(3):650-6. PubMed ID: 17368523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uterine leiomyomas with unusual histopathologic aspects. Presentation of 4 cases].
    Eleuteri Serpieri D; Buzzi M; Cesa F
    Minerva Ginecol; 1985 May; 37(5):217-24. PubMed ID: 4034066
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid-rich residual bodies and cathepsin D in the human uterus: ultrastructural and quantitative comparison between normal myometrium and leiomyoma.
    Yamazaki K; Yakumaru K; Eyden BP
    J Submicrosc Cytol Pathol; 1993 Jul; 25(3):437-47. PubMed ID: 8402543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microstructural changes in uterine leiomyomas and myometrium: a diffusion-weighted magnetic resonance imaging study.
    Erdem G; Celik O; Karakas HM; Hascalik S; Firat AK
    Gynecol Obstet Invest; 2009; 67(4):217-22. PubMed ID: 19169036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid mucopolysaccharide and mast cell variations in endometrium and some uterine tumors.
    Gupta RK; Schueller ES
    Obstet Gynecol; 1967 Oct; 30(4):510-7. PubMed ID: 4167154
    [No Abstract]   [Full Text] [Related]  

  • 9. Ovarian leiomyomas: clinicopathologic features in fifteen cases.
    Doss BJ; Wanek SM; Jacques SM; Qureshi F; Ramirez NC; Lawrence WD
    Int J Gynecol Pathol; 1999 Jan; 18(1):63-8. PubMed ID: 9891243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogenesis of morphologic variations in tumors of the uterine wall.
    Mazur MT; Kraus FT
    Am J Surg Pathol; 1980 Feb; 4(1):59-74. PubMed ID: 7361995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
    Ip PP; Lam KW; Cheung CL; Yeung MC; Pun TC; Chan QK; Cheung AN
    Am J Surg Pathol; 2007 Aug; 31(8):1215-24. PubMed ID: 17667546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
    Zhang ZL; Zhang Y; Xu BQ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
    Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
    Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine intravascular leiomyomatosis: an update and report of seven cases.
    Nogales FF; Navarro N; Martinez de Victoria JM; Contreras F; Redondo C; Herraiz MA; Seco MA; Velasco A
    Int J Gynecol Pathol; 1987; 6(4):331-9. PubMed ID: 3692675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.
    Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M
    Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small atypical leiomyomas: report of two cases.
    Scurry J; Kerdemelidis P; Fortune D
    Pathology; 2001 Aug; 33(3):319-21. PubMed ID: 11523933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ependymoma-like tumor of the mesovarium.
    Grody WW; Nieberg RK; Bhuta S
    Arch Pathol Lab Med; 1985 Mar; 109(3):291-3. PubMed ID: 3838461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the mechanism of mast cell increase in cellular leiomyoma of uterus].
    Lü JQ; Zhu XQ; Dong K; Xiang M; Lin Y; Hu Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):390-3. PubMed ID: 17697600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells in smooth muscle tumors of the uterus.
    Orii A; Mori A; Zhai YL; Toki T; Nikaido T; Fujii S
    Int J Gynecol Pathol; 1998 Oct; 17(4):336-42. PubMed ID: 9785134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.